Lifeboat Foundation

Salesforce has showcased new natural language features for enabling its Einstein AI platform to further simplify the work of sales agents, marketers and business leaders.

On ‘AI Day’ at the Dreamforce conference, members of Salesforce’s data science team demonstrated how Einstein Voice—an emerging speech interface—can be used to better access sales figures and projections, automate repetitive tasks, and receive business insights, including through Amazon’s and Google’s smart speakers.

Jim Sinai, Salesforce’s vice president of marketing, said in a keynote that Salesforce had been working on Einstein Voice for the last year to better deliver Einstein’s data discovery, deep learning and machine learning capabilities.

Continue reading “Salesforce’s Einstein has found its voice” »

Very interesting article on the ideas and daily life of the businessman and biohacker Serge Faguet.

Silicon Valley millionaire Serge Faguet thinks pills, injections and implants will turn him into a superhuman. Could they?

In a world increasingly driven by industries that rely on advanced technical learning and innovation, fluency in STEM fields (science, technology, engineering and math) becomes more vital every day. Yet our education system isn’t keeping up. Five years ago, a Business-Higher Education Forum study found that 80% of high school students either lacked interest or proficiency in STEM subjects. Meanwhile, a college and career readiness organization known as ACT reported last year that the number of students pursuing STEM careers is growing at less than 1% annually.

The Amgen Foundation is doing something about it. As the principal philanthropic arm of Amgen, the largest independent biotechnology company, the Amgen Foundation has been committed to inspiring the next generation of scientists and innovators by making immersive science education a focus of its social investments for almost 30 years. While Amgen has reached millions of patients around the world with biotechnology medicines to combat serious illnesses, such as cardiovascular disease, cancer and migraines, the Amgen Foundation has reached more than 4 million students globally—and it is poised to launch a new program called LabXchange with the potential to reach millions more.

“As a scientist, it’s clear to me that the most effective way to learn science is by doing it,” says David Reese, executive vice president of Research and Development at Amgen and member of the Amgen Foundation board of directors. “It’s time to transform the science learning experience. We need to move from information acquisition to application and exploration, from students as passive listeners to active participants in the learning process, from teachers as knowledge transmitters to facilitators and coaches.”

Continue reading “Philanthropy Assignment: Inspire Tomorrow’s Leaders With Science” »

Rory McCarthy, senior storage analyst for Wood Mackenzie Power & Renewables, illustrated for attendees how the business case for using renewables in place of natural gas is becoming more compelling following declines in solar and wind costs.

That business case is also improving as a result of massive increases in battery storage, where the U.S. leads the world in terms of operational and planned capacity.

Today, storage capacity amounts to around 6 gigawatt-hours worldwide, but Wood Mackenzie predicts a more than tenfold increase, to at least 65 gigawatt-hours, by 2022. The U.S. will continue to lead this build-out, thanks to its more mature market.

Continue reading “6 Charts Showing the Renewables Threat to Natural Gas” »

The United States uses more energy for HVAC than Africa uses for all of their energy needs.

The starry night sky seems remarkably distant from the topic of air conditioning, but it’s revolutionizing the field in quite an unexpected way. In this episode of “The Spark,” watch how scientists from across the globe are harnessing natural phenomena to drastically redesign this century-old technology.

Continue reading “This New Space Tech Could Someday Replace A/C” »

Today, we would like to share a talk given by Stephen Hilbert, President of Oisin Biotechnologies, in which he discusses treating aging and cancer by removing harmful senescent cells.

On July 12th, we hosted our first conference, Ending Age-Related Diseases: Investment Prospects & Advances in Research, at the Frederick P. Rose Auditorium, which is part of the Cooper Union campus in New York City. The packed event saw a range of people from research, investment, and the wider community coming together for a day of science and biotech business presentations and panels.

Continue reading “Treating Aging with SENSOlytics” »

Electrons tend to avoid one another as they go about their business carrying current. But certain devices, cooled to near zero temperature, can coax these loner particles out of their shells. In extreme cases, electrons will interact in unusual ways, causing strange quantum entities to emerge.

Today, we want to let you know that the documentary Paywall: The Business of Scholarship is now available in both English and Russian. This is a documentary exploring the crisis in scientific journal publication and the excessive fees that some publishers charge to access knowledge.

Holding scientific knowledge to ransom

Continue reading “Paywall: The Business of Scholarship Documentary in English and Russian” »

The move means grantees from these 11 funders—which include the national funding agencies in the United Kingdom, the Netherlands, and France as well as Italy’s National Institute for Nuclear Physics—will have to forgo publishing in thousands of journals, including high-profile ones such as Nature, Science, Cell, and The Lancet, unless those journals change their business model. “We think this could create a tipping point,” says Marc Schiltz, president of Science Europe, the Brussels-based association of science organizations that helped coordinate the plan. “Really the idea was to make a big, decisive step—not to come up with another statement or an expression of intent.”

Bold move is intended to trigger open-access tipping point.